Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04982952 · ClinicalTrials.gov registry record · NA
Contingency Management for Smoking Cessation
A NA study of Smoking Cessation and Smoking, Tobacco, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
- 2
- Study locations
NCT04982952 is a NA study of Smoking Cessation and Smoking, Tobacco that has completed, run by University of California, San Francisco. The registered enrollment target is 83 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04982952, a NA study of Smoking Cessation and Smoking, Tobacco, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
- 2
- Study locations
Study Summary
The prevalence of smoking in the homeless population (70%) is over 4 times that of the general population (15%). Homeless adults have not experienced similar declines in tobacco use as the general population has over the past three decades. Homeless adults are interested in smoking cessation and make quit attempts, but are less successful in quitting smoking than the general population. Trials of group behavioral counseling and pharmacotherapy for smoking cessation have not led to substantial long-term abstinence (i.e., abstinence for 6 months or more), suggesting that these interventions alone are insufficient to improve quit rates among homeless adults. Many homeless adults seek health care in safety net clinics; these clinics could bring cessation interventions to scale. Contingency management is a powerful behavior change intervention that reinforces positive health behaviors through the provision of modest incentives (e.g., cash). In this pilot randomized controlled trial, the investigator will test the feasibility and acceptability of a contingency management intervention that provides incentives for smoking cessation for people experiencing homelessness.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management - Increasing
- BEHAVIORAL Fixed payments
Study Locations (2)
California
- The Richard H. Fine's People's Clinic - San Francisco
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04982952
The ClinicalTrials.gov registry entry for NCT04982952 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (82% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Contingency Management - Increasing is the first listed.
NCT04982952 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04982952 about?
NCT04982952 is a clinical study titled "Contingency Management for Smoking Cessation". The prevalence of smoking in the homeless population (70%) is over 4 times that of the general population (15%). Homeless adults have not experienced similar declines in tobacco use as the general population has over the past three decades. Homeless adults are interested in smoking cessation and mak...
What is the current status of trial NCT04982952?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2021-11-09. Estimated completion is 2024-06-30.
What conditions does trial NCT04982952 study?
This clinical trial studies the following conditions: Smoking Cessation, Smoking, Tobacco, Smoking Reduction.
What interventions are being tested in trial NCT04982952?
The interventions under investigation include: Contingency Management - Increasing (BEHAVIORAL), Fixed payments (BEHAVIORAL).
Who is sponsoring clinical trial NCT04982952?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04982952 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.